$RWAYL

Runway Growth Finance Corp.

No enriched coverage for $RWAYL in the last 7 days.

No SEC Form 4 filings for $RWAYL in the last 30 days.

Med

Runway Growth Finance Corp. (NASDAQ:RWAY) Given Consensus Recommendation of "Hold" by Analysts

Runway Growth Finance Corp. (NASDAQ:RWAY) has received an average "Hold" rating from seven analysts, with an average 12-month price target of $11.10. The company recently surpassed analysts' EPS and revenue estimates, reporting strong financial results including a net margin of 38.92%. Institutional investors hold a significant portion of the stock, with recent increases in stakes by several funds.

Runway Growth Finance Launches Unsecured Notes Offering

Runway Growth Finance (RWAY) has initiated an underwritten offering of unsecured notes to be listed on the Nasdaq Global Select Market. The net proceeds will primarily be used to repay existing debt, including $51.75 million of 8.00% notes due in December 2027, and to support the prior acquisition of SWK Holdings, which will boost its healthcare investment portfolio to 31%. Despite a 14% dividend yield and a 30% discount to NAV, analysts maintain a cautious outlook on RWAY's future performance, with an average 1-year price target of $10.57.